Komori
Monthly7476AS ONE CORPORATIONTrading & Wholesale

Notice of Preliminary Standalone Monthly Results for July 2026

Standalone sales in July 2026 were ¥9,788 million, up 9.8% year on year. All 3 major business areas, Laboratory, Industry and Medical, reported higher sales.

Worth reading
54Recurring
Scored from 4 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
9.8
Year-on-year (%)
Wording
Conditional
How definitive the wording is.

Sales for this month

July 2026Fiscal year ending March 2027
9,788¥ million
Net Sales
-90.2%
The center line represents the same level as the same month of the previous year (100). The distance from the line represents the year-on-year change.
Monthly Commentary

All 3 major business areas reported year-on-year sales growth in July. Sales were up 9.8% year on year, as were sales per day.

Factors Affecting the Change

Strong corporate R&D investment, Centralized purchasing system, Strong sales to the semiconductor sector, Introduction of equipment utilizing government support programs

Monthly trend for the same period last year

Month April / Net Sales ¥8,228 million, Month May / Net Sales ¥7,792 million, Month June / Net Sales ¥8,524 million, Month July / Net Sales ¥8,911 million, Month August / Net Sales ¥7,262 million, Month September / Net Sales ¥8,423 million, Month October / Net Sales ¥9,140 million, Month November / Net Sales ¥7,880 million, Month December / Net Sales ¥9,513 million, Month January / Net Sales ¥9,314 million, Month February / Net Sales ¥9,290 million, Month March / Net Sales ¥11,327 million

Scope of aggregation: Standalone

Sales for this month
ItemDetails
Month CoveredJuly 2026
Fiscal Year CoveredFiscal year ending March 2027
Scope of aggregationStandalone
Net sales for the month¥9,788 million
Year-on-year change in monthly net sales9.8
Year-on-year change by categoryName Laboratory / Year on year 9.6, Name Industry / Year on year 9.8, Name Medical / Year on year 7.9
Sales by categoryLaboratory ¥5,586 million, Industry ¥2,349 million, Medical ¥1,532 million
Monthly CommentaryAll 3 major business areas reported year-on-year sales growth in July. Sales were up 9.8% year on year, as were sales per day.
Factors Affecting the ChangeStrong corporate R&D investment, Centralized purchasing system, Strong sales to the semiconductor sector, Introduction of equipment utilizing government support programs
Monthly trend for the same period last yearMonth April / Net Sales ¥8,228 million, Month May / Net Sales ¥7,792 million, Month June / Net Sales ¥8,524 million, Month July / Net Sales ¥8,911 million, Month August / Net Sales ¥7,262 million, Month September / Net Sales ¥8,423 million, Month October / Net Sales ¥9,140 million, Month November / Net Sales ¥7,880 million, Month December / Net Sales ¥9,513 million, Month January / Net Sales ¥9,314 million, Month February / Net Sales ¥9,290 million, Month March / Net Sales ¥11,327 million
Items this document does not state (12)
Total-store sales, year on yearSame-Store Sales, Year on YearYear-on-Year Change in Customer CountYear-on-Year Change in Average Spend per CustomerCumulative Sales from Start of PeriodCumulative Year-on-Year Change from Start of PeriodKey KPIsNumber of Stores at Period-EndNumber of stores opened during the monthNumber of stores closed during the monthMeasures from the following month onwardNext Scheduled Disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In Laboratory, the centralized purchasing system drove results against a backdrop of strong corporate R&D investment. Industry performed well in sales to the semiconductor sector. In Medical, the introduction of equipment utilizing government support programs contributed to results.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Preliminary Standalone Monthly Results for July 2026 | AS ONE CORPORATION (7476) timely disclosure | Komori